JUNE 2004
"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.
 

Please pass these updates along to your colleagues.

  eBulletin Index


NEW THIS MONTH

 

**NEW** ISPOR Board of Directors Election Results

**NEW** 9th Annual International Meeting Contributed Paper Award Recipients

**NEW** 9th Annual International Meeting Photo Gallery

**NEW** Risk Management SIG Reorganized into Four Areas

**NEW** Clinical Practice SIG Reorganized Around Theme: Dataset to Bedside

 

ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

9.       Employment in Pharmacoeconomics and Outcomes Research

10.    Membership

 


  1. PUBLICATIONS

Top

 

VALUE IN HEALTH

 

Value in Health: Volume 7, Issue 3, May/June 2004 9th Annual Meeting Contributed Paper Abstracts is online and available this month at: http://www.ispor.org/valueinhealth_index.asp

 

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 1000.

 


 

 

  1. ISPOR MEETINGS AND CONGRESSES

Top

  

 

7TH ANNUAL EUROPEAN CONGRESS

24-26 October 2004, CCH Congress Centrum Hamburg, Hamburg, Germany

 

CALL FOR ABSTRACTS AVAILABLE ONLINE

http://www.ispor.org/congresses/germany1004/abstract_instructions.asp

SUBMIT YOUR ABSTRACT NOW!

Abstract Deadline: 21 June 2004

Early Registration Deadline: 28 September 2004

 

MEETING AT A GLANCE

http://www.ispor.org/congresses/germany1004/index.asp

 

Sign up for Exhibit Space, contract available online a

https://www.ispor.org/forms/contractgermany1004.htm

Sponsorship Opportunities still available, for more information go to

http://www.ispor.org/congresses/germany1004/sponsor.asp

 

 

9TH ANNUAL INTERNATIONAL MEETING

May 16-19, 2004, Crystal Gateway Marriott, Arlington, VA, USA

 

**NEW** Photo Gallery

http://www.ispor.org/meetings/va0504/autositepg/default.asp

 

 


 

  1. EDUCATION ACTIVITIES

Top

 

 

SHORT COURSES- ISPOR 7TH ANNUAL EUROPEAN CONGRESS

13 ISPOR SHORT COURSES prior to the ISPOR 7th Annual European Congress 23-24 October NOW available at:http://www.ispor.org/congresses/germany1004/index.asp

 


 

 

  1. STUDENT NEWS

Top

 

NEW ISPOR STUDENT NETWORK CHAIR

Larry Humble, RPh, Graduate Student, The University of Louisiana at Monroe, Monroe, LA USA, is the newly elected chair for the Student Network for 2004-2005.

 

 


 

 

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

 

Summary of Activities at the 9th Annual Meeting:

 

CLINICAL PRACTICE SIG

**NEW** Reorganized around theme: Dataset to Bedside

Projects in development for the year:

  • Education Working Group:

A one-hour scripted slide show for clinicians on the basics of pharmacoeconomics and application of outcomes research.

  • Review and Planning for 10th Annual International Meeting Working Group

A ‘clinical track' contributed issue panel / workshop / presentation at Annual Meeting Topic: translation of research into clinical recommendations.

  • Standardized Reporting Working Group

Develop a standardized reporting format for outcomes research or economic evaluations designed for clinicians' use.

 

For more details, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

RISK MANAGEMENT SIG

**NEW** Reorganized into four topics:

·         Communication Working Group
Co-Chairs: Ateeq Rahman PhD, MBA & Paul Stang PhD

·         Identification of Risk Working Group
Co-chair: Nicholas Lipskiy PhD, MBA & Larry Liu MD, PhD

·         Interventions/Implementation Working Group

Co-Chair: Anthony Lockett MBA, MD, PhD & Paul Stang, PhD

·         Legal and Regulatory Implications Working Group
Chair: TBD
please email emolsen@ispor.org if you are interested in this position.

 

For more details, please visit: http://www.ispor.org/sigs/rm.asp

 

MEDICATION COMPLIANCE SIG
Contributed Workshops presented at the 9th Annual International Meeting:

 

W2: Patient Compliance and Persistence with Prescribed Medication: Measurement and Health Economic Impact


W10: Methods In Compliance Evaluation: Determining and Analyzing Appropriate Measures

 

W18: Medication Compliance (Adherence): Issues and Definitions Consensus Workshop

 

W26: Education Issues in Medication Adherence

 


QUALITY OF LIFE SIG

Contributed Workshops presented at the 9th Annual International Meeting:

 

W6: Advances in Mapping Health-Related Quality of Life: An Eq-5d Index Based on Sf-36 Data

 

W7: Applying Item Response Theory Modeling for Improving Health Outcomes Measurement

 

W23: Challenges in Developing Outcome Instruments to Show the Value of New Therapies in Sever Mental Illness

 


PATIENT REGISTRY SIG

Convened an open meeting of all interested members.

 

* Fun Fact / Statistic: 612 ISPOR members have joined a SIG

 

Special Interest Group membership is open to ALL ISPOR members.

To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


 

 

  1. ISPOR COMMITTEE AND TASK FORCE ACTIVITIES

Top

 

**NEW** ISPOR Board of Directors Election Results

 

The new elected members of the ISPOR Board of Directors will take office on July 1, 2004.  They are:

 

2004-2005 President-elect and 2005-2006 President

Peter J. Neumann, ScD, Associate Professor of Policy and Decision Sciences, Harvard School of Public Health, Boston, MA, USA

 

2004-2006 Directors

Isao Kamae MD, DrPH, Professor of Biostatistics and Health Decision Sciences, Kobe University, Kobe, Japan

Capt. Laurie Beth Burke, RPh, MPH, Director, Study Endpoints and Label Development, Office of New Drugs, CDER, FDA, Rockville, MD, USA

Jens Grueger PhD, Head of Pricing and Health Economics, Novartis Pharmaceuticals, Basil, Switzerland

 

These board members will join the incumbent Board members:

 

2004-2005 President

Lieven Annemans PhD, Director, HEDM, Meise, Belgium

 

2004-2005 Past President

Past-President Sean D. Sullivan, PhD, Professor, University of Washington
Seattle, WA, USA

 

2003-2005 Directors

Randel E. Richner BSN, MPH, Vice President, Federal Affairs, Reimbursement and Outcomes Planning, Boston Scientific Corporation, Boston, MA, USA

Marcus D. Wilson PharmD, President, Chief Executive Officer,
Health Core, Inc., Wilmington, DE, USA

 

 

AWARD COMMITTEE ACTIVITIES

 

**NEW** ISPOR NINTH ANNUAL INTERNATIONAL MEETING CONTRIBUTED PAPER AWARDS RECIPIENTS

 

BEST CONTRIBUTED PAPER AWARDS PODIUM PRESENTATIONS

GENERAL


HM4
HOW ROBUST IS COST-EFFECTIVENESS RATIO TO MISSING DATA IMPUTATION? ANALYSIS OF LONG-TERM CLINICAL TRIAL IN PARKINSONS DISEASE

Noyes K, Holloway RG, Dick AW
University of Rochester School of Medicine, Rochester, NY, USA  

PE1
ASSESSING EFFECTIVENESS IN THE PRESENCE OF TREATMENT SWITCHING: DATA FROM AN EFFECTIVENESS STUDY OF ANTIPSYCHOTICS

Faries D1, Nyhuis A1, Tunis SL1, Hernan M2
1Eli Lilly and Company, Indianapolis, IN, USA; 2Harvard School of Public Health, Boston, MA, USA


RI3
COST-EFFECTIVENESS OF INFLUENZA VACCINE IN 6-24 MONTH OLD CHILDREN

Woolcott JC1, Marra F1, Brunham RC2
1BC Centre for Disease Control, Vancouver, BC, Canada; 2University of British Columbia Centre for Disease Control, Vancouver, BC, Canada  

NEW INVESTIGATOR


CV1
HEALTH PREFERENCES AFTER CABG OR PCI FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
Radeva J, Reed S, Weinfurt K, Anstrom K, Velazquez E, Schulman K
Duke Clinical Research Institute, Durham, NC, USA  

HP1
EVALUATION OF GENERIC DISPENSING INCENTIVE PROGRAM (GDIP)
Hong SH

University of Arkansas for Medical Sciences, Little Rock, AR, USA  

MH4
ASSESSMENT OF HEALTH STATE UTILITIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN CHILDREN USING PARENT-BASED STANDARD GAMBLE SCORES

Secnik K1, Cottrell S2, Matza L3, Edgell E4, Aristides M5, Tilden D2, Burridge J5, Mannix S6
1Eli Lilly and Company, Indianapolis, IN, USA; 2M-TAG Pty Ltd., London, England; 3MEDTAP International, Bethesda, MD, USA; 4Lilly Research Centre, Windlesham, United Kingdom; 5M-TAG Limited, London, United Kingdom; 6MEDTAP International, Inc, Bethesda, MD, USA

STUDENT


AC3
COMPARISION OF ADHERENCE TO ANTIHYPERTENSIVES IN A MANAGED CARE POPULATION
Naik RK1, Borrego ME1, Gupchup GV1, D'Angio R2, Sabrsula S3
1University of New Mexico, Albuquerque, NM, USA; 2Pfizer Inc, Albuquerque, NM, USA; 3Firstcare MCO, Albuquerque, NM, USA

OP2
COMPARISON OF DISCRETE CHOICE EXPERIMENT (DCE) WITH VISUAL ANALOG SCALING (VAS) METHODS FOR ESTIMATING PREFERENCES FOR PHYSICAL DISABILITY STATES
Banks JL1, Netten A2, Ryan M3, Watson V4, Salas M5

1University of Kent at Canterbury, Lincoln, MA, USA; 2University of Kent at Canterbury, Canterbury, Kent, United Kingdom; 3University of Aberdeen, Aberdeen, United Kingdom; 4University of Aberdeen Medical School, Aberdeen, United Kingdom; 5Erasmus University Medical School, Rotterdam, Netherlands

SC4E
ECONOMIC EVALUATION OF SCREENING FOR THE A-ADDUCIN GENE VARIANT IN HYPERTENSIVE PATIENTS
Meckley LM, Veenstra DL
University of Washington, Seattle, WA, USA

BEST CONTRIBUTED PAPER AWARDS POSTER PRESENTATIONS

GENERAL


PAR18
RACIAL DISPARITIES IN PRESCRIBING OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS OVER OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS IN A MEDICAID MANAGED CARE POPULATION
Shaya FT, Blume SW, Blanchette CM, Mullins CD

University of Maryland, Baltimore, MD, USA

PCV47
THE NATIONAL ANTICOAGULATION BENCHMARK AND OUTCOMES REPORT (NABOR™): EVIDENCE OF A SIGNIFICANT DIFFERENCE BETWEEN GUIDELINES AND ACTUAL PRACTICE

Shillington A1, Tapson V2, Hyers T3, Becker R2, Colgan K1
1EPI-Q, Inc, Oakbrook Terrace, IL, USA; 2Duke University Medical Center, Durham, NC, USA; 3CARE Clinical Research, St. Louis, MO, USA

PHP34
EXPLICIT INDICATORS TO MEASURE PREVENTABLE DRUG-RELATED MORBIDITY IN AN ELDERLY POPULATION
Faris RJ
University of Tennessee, Memphis, TN, USA

NEW INVESTIGATOR

PCV42
PERSISTENCE AND ADHERENCE TO STATIN THERAPY IN A MANAGED CARE SETTING
Quach C1, Nichol MB2, Chen L1, Patel BV1, Berenbeim D1

1MedImpact Health Care Systems Inc, San Diego, CA, USA; 2University of Southern California, Los Angeles, CA, USA

PCV51
RETROSPECTIVE EVALUATION OF UTILIZATION PATTERNS OF BETA-BLOCKER THERAPY IN CONGESTIVE HEART FAILURE PATIENTS IN A MANAGED CARE ENVIRONMENT

Thaker DJ, Godley PJ, Browne BA, Rohack J, Houck P
Scott & White, Temple, TX, USA

PIN1
OUTCOMES OF AN INTERACTIVE VOICE RESPONSE (IVR) REMINDER SYSTEM TO PROMOTE MANAGED CARE ORGANIZATION (MCO) MEMBERS' ATTAINMENT OF INFLUENZA IMMUNIZATION
Sikirica V1, Crawford A1, Goldfarb N1, Nash D1, Popiel R2, Patel M2, Wang C2, Chu J2

1Department of Health Policy, Jefferson Medical College, Philadelphia, PA, USA; 2Horizon Blue Cross Blue Shield of New Jersey, Newark, NJ, USA

STUDENT

PAR7
ASSESSMENT OF PATIENT-REPORTED OUTCOMES AMONG OSTEOARTHRITIC PATIENTS
Gandra SR, Lawrence LW
The University of Louisiana at Monroe, Monroe, LA, USA

PCN20
PRELIMINARY ECONOMIC ANALYSIS OF THE AMERICAN CANCER SOCIETY GUIDELINES FOR MAMMOGRAPHY SCREENING IN AVERAGE-RISK WOMEN UNDER 70 YEARS OF AGE
Zammit D, Hay J
University of Southern California, Los Angeles, CA, USA

PMD15
RELIABILITY AND VALIDITY OF THE EQ-5D SELF-REPORT QUESTIONNAIRE IN TAIWAN POPULATION
Chang TJ, Tarn YH
National Defense Medical Center, Taipei, Taiwan

 

 

2004 ISPOR SCIENTIFIC AWARDEES: http://www.ispor.org/awards/index_.asp

 

2004 ISPOR SERVICE AWARDEES: http://www.ispor.org/awards/service/service.asp

 

2004 ISPOR DISTINGUISHED SERVICE AWARDEES : http://www.ispor.org/awards/service/distinguish.asp

 

RANDOMIZED CLINICAL TRIALS ALONGSIDE COST EFFECTIVENESS ANALYSIS (RCT-CEA) TASK FORCE

 

Randomized Clinical Trials Alongside Cost Effectiveness Analysis (RCT-CEA) held it's first public forum at the ISPOR 9th Annual International Meeting in Arlington, Virginia, May 17, 2004.  To view this presentation, go to http://www.ispor.org/workpaper/clinical_trial.asp  

 

The next presentation of this task force will be held at the 7th Annual European Congress to be held October 24-26, 2004 in Hamburg, Germany.

 


  1. HOT TOPICS

Top

 

SENATOR TO UNVEIL DRUG IMPORTATION BILL THIS WEEK

 

WASHINGTON (Reuters) - Recognizing voter concern about the high cost of medicines, a key U.S. Senate committee chairman said Tuesday he plans to unveil this week legislation that would allow importation of cheaper drugs from Canada and other countries.

 

For full text of the article, go to: http:// story.news.yahoo.com/news?tmpl=story&cid=594&ncid=594&e=3&u=/nm/20040601/hl_nm/congress_drugs_dc

 


 

 

  1. IMPORTANT DATES TO REMEMBER

Top

 

June 21, 2004Deadline to submit abstracts for the 7th Annual European Congress.  For submission guidelines go to: http://www.ispor.org/congresses/germany1004/abstract_instructions.asp.

 

September 28, 2004Early registration deadline for the 7th Annual European Congress.  For register, go to: http://www.ispor.org/members/events/closed.asp

 

October 24-26, 2004 – ISPOR 7th Annual European Congress, CCH Congress Centrum Hamburg, Hamburg, Germany.

 


  1. EMPLOYMENT

Top

9 New positions posted at the ISPOR Website since the last e-bulletin

Careers

 

Advertise your positions on ISPOR Web (up to 1 million hits per month)

 

PRAP, Professional Recruitment Center:

At the ISPOR 9th Annual International Meeting, the ISPOR PRAP Center was a great success. With over 33 positions and 65 candidates, the center was constantly in motion.  

 

For information on PRAP at the 7th Annual European Congress, go to: Careers

 


  1. ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website.

 


eBulletin Index